Skip to Main Content

We have a new app!

Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.

Download the Access App here: iOS and Android. Learn more here!

INTRODUCTION

The incidence of dialysis-requiring acute kidney injury (AKI-D) has increased in the past decade in the United States. From 2000 to 2009, there were 1.09 million hospitalizations (95% confidence interval [CI], 1.04–1.15 million) with AKI-D in the United States. From 2007 to 2009, the population incidence of AKI-D increased by 11% per year (95% CI, 1.07–1.16; P < 0.001).1 Hospitalized patients with AKI-D were older than their counterparts who did not have AKI-D (63.4 vs 47.6 years), were more likely to be male (57.3% vs 41.1%), to be black (15.6% vs 10.2%), to have sepsis (27.7% vs 2.6%), to have heart failure (6.2% vs 2.7%), and to undergo cardiac catheterization (5.2% vs 4.4%) and mechanical ventilation (29.9% vs 2.4%).1 The temporal trend in the 6 diagnoses—septicemia, hypertension, respiratory failure, coagulation/hemorrhagic disorders, shock, and liver disease—sufficiently and fully accounted for the temporal trend in AKI-D.2 This chapter will discuss the diagnosis of acute kidney injury and types of renal replacement therapy.

DIAGNOSIS OF ACUTE KIDNEY INJURY

Acute kidney injury is considered when there is an abrupt decrease in urine output. Diagnostic criteria have gone through an evolution, from RIFLE (risk, injury, failure, loss of kidney function, and end-stage kidney disease) criteria, AKIN (Acute Kidney Injury Network) criteria, and now KDIGO (Kidney Disease: Improving Global Outcomes) criteria.3-5 This was deemed necessary for research, clinical, and prognostication purposes. See Tables 26-1 and 26-2.

TABLE 26-1RIFLE and AKIN Criteria

Pop-up div Successfully Displayed

This div only appears when the trigger link is hovered over. Otherwise it is hidden from view.